Prestige Consumer Healthcare (PBH) Profit After Tax (QoQ) (2010 - 2025)
Prestige Consumer Healthcare (PBH) Profit After Tax (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -96.81% |
| Sep 30, 2025 | 693.23% |
| Jun 30, 2025 | -88.49% |
| Mar 31, 2025 | -23.05% |
| Dec 31, 2024 | 3.14% |
| Sep 30, 2024 | 20.60% |
| Jun 30, 2024 | 5.46% |
| Mar 31, 2024 | 523.27% |
| Dec 31, 2023 | 297.28% |
| Sep 30, 2023 | -107.19% |
| Jun 30, 2023 | 2,636.39% |
| Mar 31, 2023 | -103.99% |
| Dec 31, 2022 | 829.85% |
| Sep 30, 2022 | -112.88% |
| Jun 30, 2022 | 4.57% |
| Mar 31, 2022 | 5.26% |
| Dec 31, 2021 | 1,476.89% |
| Sep 30, 2021 | -275.21% |
| Jun 30, 2021 | -100.60% |
| Mar 31, 2021 | 1,324.41% |